V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010593 | 280006250 | 1.47 | 94.1 | null | 2017-11-28 | 2018-01-12 | CMV | 02 | N | 280029691 | PERTUZUMAB + TRASTUZUMAB |
| 280010594 | 280006254 | 1.67 | 73.6 | Palliative (P) | 2018-05-27 | 2018-05-30 | Capecitabine (21days) + Carboplatin | N | null | 280029694 | CAPECITABINE + OXALIPLATIN |
| 280010595 | 280006258 | 1.67 | 73.85 | Neo-adjuvant (N) | 2017-11-28 | 2017-12-09 | Capecitabine (14 day) + Irinotecan | 2 | N | 280029707 | VIDE |
| 280010596 | 280006263 | 1.82 | 72.6 | Adjuvant (A) | 2013-10-30 | 2013-11-19 | ECX | 02 | N | 280029715 | VIDE |
| 280010597 | 280006266 | 1.75 | 92.7 | null | 2014-10-08 | 2014-11-20 | LANREOTIDE | N | N | 280029727 | KESTREL TRIAL |
| 280010598 | 280010725 | null | 80.95 | Curative (C) | 2015-09-10 | 2016-07-01 | GemCarbo Days 1+8 | N | N | 280029727 | CARBO + FLUOROURACIL |
| 280010599 | 280011943 | 1.67 | 41.3 | Neo-adjuvant (N) | 2016-03-17 | 2016-07-06 | NIVOLUMAB | null | null | 280029733 | BCG |
| 280010600 | 280009280 | 1.58 | 82.8 | Neo-adjuvant (N) | 2016-05-16 | 2017-05-02 | Carboplatin + Cetuximab (>Cycle 2) | N | N | 280029753 | ETOPOSIDE |
| 280010601 | 280006272 | 1.89 | 44.8 | Palliative (P) | null | 2015-11-09 | Capecitabine + Cisplatin | N | null | 280029773 | KESTREL TRIAL |
| 280010602 | 280006276 | null | 86.3 | Palliative (P) | 2018-01-31 | 2018-02-09 | Hydroxycarbamide | N | N | 280029779 | IVADO |
| 280010603 | 280006277 | 1.82 | 77.3 | Palliative (P) | 2018-12-17 | 2019-04-01 | CARBOPLATIN + FLUOROURACIL | N | N | 280029781 | IVADO |
| 280010604 | 280006281 | 0 | 69 | null | 2016-06-08 | 2016-07-24 | Vinorelbine (oral) | N | N | 280029782 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010605 | 280006288 | 1.73 | 76.3 | Palliative (P) | 2016-07-14 | 2016-08-07 | OCTREOTIDE | N | N | 280029789 | VIDE |
| 280010606 | 280009287 | null | 74.8 | Curative (C) | 2015-06-08 | 2015-06-25 | CMV | N | N | 280029796 | IPILIMUMAB |
| 280010607 | 280006292 | null | 94.1 | null | 2014-06-10 | 2014-06-11 | Rituximab | N | N | 280029801 | CARBO + FLUOROURACIL |
| 280010608 | 280009289 | null | 85.8 | Curative (C) | 2017-05-21 | 2017-06-24 | Capecitabine (14 days)+Carboplatin | N | N | 280029813 | PACLITAXEL + TRASTUZUMAB |
| 280010609 | 280006295 | 1.7 | 11.1 | Palliative (P) | 2015-12-16 | 2016-06-24 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 280029814 | VINCRISTINE |
| 280010610 | 280006296 | 1.56 | 79.2 | Neo-adjuvant (N) | 2017-11-02 | 2017-11-19 | Dacarbazine | N | N | 280029819 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280010611 | 280006297 | 1.6 | 88.4 | Palliative (P) | 2017-08-19 | 2017-09-07 | Mitomycin Intravesical | 02 | null | 280029826 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280010612 | 280006298 | 1.72 | 91.6 | Curative (C) | 2014-09-20 | 2014-09-24 | FEC | null | null | 280029830 | IRINOTECAN + VINCRISTINE |
| 280010613 | 280006299 | 1.76 | 19.1 | Palliative (P) | null | 2017-11-14 | Capecitabine + Cisplatin | 01 | N | 280029832 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280010614 | 280006299 | 1.68 | 68 | null | 2014-03-18 | 2014-09-14 | VIDE | 02 | N | 280029832 | CARBOPLATIN + CETUXIMAB + FU |
| 280010615 | 280006301 | 1.8 | 79.7 | Palliative (P) | 2018-04-02 | 2018-04-29 | Dactinomycin + Vincristine | Y | N | 280029852 | CARBO + FLUOROURACIL |
| 280010616 | 280006302 | 1.73 | 77.3 | Palliative (P) | 2016-10-03 | 2016-10-05 | CARBOPLATIN + FLUOROURACIL | N | N | 280029852 | MELPHALAN |
| 280010617 | 280006304 | null | 115 | Palliative (P) | 2018-03-01 | 2018-03-09 | Cyclophosphamide + Vincristine | N | N | 280029855 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010618 | 280010737 | 1.67 | 63 | Palliative (P) | 2016-12-28 | 2016-12-31 | Mitomycin Intravesical | 01 | N | 280029867 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010619 | 280006308 | 1.79 | 115 | Palliative (P) | 2016-03-14 | 2016-03-14 | CASPS TRIAL | N | null | 280029870 | LIPOSOMAL DOXORUBICIN |
| 280010620 | 280006309 | 1.73 | 79.4 | Curative (C) | 2019-05-19 | 2019-05-19 | Pemetrexed | 02 | N | 280029884 | CAPECITABINE |
| 280010621 | 280006312 | 1.76 | 89.2 | Palliative (P) | 2014-06-15 | 2014-12-27 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280029896 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010622 | 280006314 | 1.77 | 89.2 | Palliative (P) | 2017-12-30 | 2017-12-30 | Docetaxel 75mg/m2 (21 day) | N | N | 280029901 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010623 | 280006316 | 1.81 | null | Palliative (P) | 2015-08-20 | 2015-08-20 | IVADo | 02 | null | 280029914 | BENDAMUSTINE + RITUXIMAB |
| 280010624 | 280009305 | 1.7 | 68 | Palliative (P) | 2016-05-16 | 2016-05-17 | IPM | N | N | 280029932 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010625 | 280006318 | 1.86 | null | Palliative (P) | 2018-12-18 | 2018-12-18 | Rituximab | 02 | N | 280029950 | PAZOPANIB |
| 280010626 | 280006319 | null | 85.1 | Palliative (P) | null | 2016-01-22 | BEP 5 Day | null | null | 280029951 | VIDE |
| 280010627 | 280006320 | 1.68 | 83 | Palliative (P) | 2018-12-31 | 2019-05-21 | Pemetrexed | 2 | N | 280029953 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280010628 | 280006324 | null | 96 | Palliative (P) | 2017-02-06 | 2017-08-04 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280029967 | CISPLATIN + DOCETAXEL |
| 280010629 | 280006325 | 1.72 | null | Curative (C) | 2016-11-27 | 2016-11-29 | Docetaxel 100mg/m2 (21 day) | 2 | N | 280029968 | VINCRISTINE |
| 280010630 | 280006328 | 1.77 | 83.8 | Adjuvant (A) | 2017-11-23 | 2018-03-11 | Cyclophosphamide High Dose | N | N | 280029973 | DOCETAXEL |
| 280010631 | 280011433 | 1.77 | null | Disease modification (D) | null | 2014-09-09 | Bevacizumab + Cape + Oxali 14day | null | Y | 280029985 | CAPECITABINE |
| 280010632 | 280006331 | 1.72 | 79.8 | Neo-adjuvant (N) | 2018-05-27 | 2018-05-31 | NIVOLUMAB | 2 | N | 280029988 | VIDE |
| 280010633 | 280006331 | 1.8 | null | Adjuvant (A) | 2015-08-24 | 2015-09-12 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029988 | VIDE |
| 280010634 | 280011774 | 1.8 | 90 | Palliative (P) | 2014-03-26 | 2014-04-17 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 280029991 | PAZOPANIB |
| 280010635 | 280006332 | 1.73 | 76.5 | Curative (C) | 2018-03-25 | 2018-04-15 | VIDE | N | N | 280030002 | VIA |
| 280010636 | 280006334 | 1.65 | 82.7 | Palliative (P) | 2014-05-23 | 2014-06-10 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | N | N | 280030003 | BCG |
| 280010637 | 280006338 | 1.8 | 65 | Palliative (P) | 2017-03-04 | 2017-03-16 | CARBOPLATIN + GEMCITABINE | 2 | N | 280030008 | CISPLATIN + FLUOROURACIL + RT |
| 280010638 | 280006341 | 1.67 | 61.3 | Palliative (P) | 2018-05-28 | 2018-06-12 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 280030024 | VIA |
| 280010639 | 280006342 | 1.69 | 85.1 | Palliative (P) | 2016-03-16 | 2016-03-16 | Erlotinib | Y | N | 280030030 | CISPLATIN + FLUOROURACIL + RT |
| 280010640 | 280006343 | 1.81 | null | Curative (C) | 2017-12-27 | 2017-12-28 | IFOSFAMIDE + VINCRISTINE | N | N | 280030032 | BUSULFAN + MELPHALAN |
| 280010641 | 280006346 | 1.87 | 74.3 | Palliative (P) | 2016-07-30 | 2017-12-04 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030037 | VINCRISTINE |
| 280010642 | 280006347 | 1.71 | 68 | Palliative (P) | 2015-09-03 | 2015-09-03 | PEMBROLIZUMAB | 2 | N | 280030045 | IPILIMUMAB |